Literature DB >> 36092879

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer.

Ji Liu1, Jianli Ma2, Qingyuan Zhang1.   

Abstract

Background: Triple-negative breast cancer remains a highly malignant disease due to the lack of specific targeted therapy and immunotherapy. A growing body of evidence supports the role of pyroptosis in tumorigenesis and prognosis, but further exploration is needed to improve our understanding of the tumor microenvironment in patients with triple-negative breast cancer.
Methods: Consensus clustering analysis was performed to construct pattern clusters. A correlation analysis was conducted between the pattern clusters and the tumor microenvironment using GSVA, ESTIMATE, and CIBERSORT. Then, a risk score and a nomogram were constructed and verified to predict overall survival.
Results: Two pyro-clusters and three pyro-gene clusters that differed significantly in terms of prognosis, biological processes, clinical features, and tumor microenvironment were identified. The different clusters corresponded to different immune expression profiles. The constructed risk score predicted patient prognosis and response to immunotherapy. Patients with low risk scores exhibited favorable outcomes with increased immune cell infiltration and expression of immune checkpoint molecules. Compared to other models, the nomogram was extremely effective in predicting prognosis.
Conclusion: In the landscape of the immune microenvironment, pyroptosis-mediated pattern clusters differed markedly. Both the developed risk score and the nomogram were effective predictive models. These findings could help develop customized treatment for patients with triple-negative breast cancer.
Copyright © 2022 Liu, Ma and Zhang.

Entities:  

Keywords:  immune infiltration; immunotherapy; pyroptosis; triple-negative breast cancer; tumor microenvironment

Year:  2022        PMID: 36092879      PMCID: PMC9453819          DOI: 10.3389/fgene.2022.929870

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.772


  35 in total

1.  Triple-negative breast cancer: clinical features and patterns of recurrence.

Authors:  Rebecca Dent; Maureen Trudeau; Kathleen I Pritchard; Wedad M Hanna; Harriet K Kahn; Carol A Sawka; Lavina A Lickley; Ellen Rawlinson; Ping Sun; Steven A Narod
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

Review 2.  How to build and interpret a nomogram for cancer prognosis.

Authors:  Alexia Iasonos; Deborah Schrag; Ganesh V Raj; Katherine S Panageas
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

Review 3.  Immunological hallmarks of stromal cells in the tumour microenvironment.

Authors:  Shannon J Turley; Viviana Cremasco; Jillian L Astarita
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

4.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking.

Authors:  Matthew D Wilkerson; D Neil Hayes
Journal:  Bioinformatics       Date:  2010-04-28       Impact factor: 6.937

Review 5.  Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer.

Authors:  Xiaoqiang Tang
Journal:  Cancer Lett       Date:  2013-01-21       Impact factor: 8.679

6.  In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

Authors:  Franck Pagès; Amos Kirilovsky; Bernhard Mlecnik; Martin Asslaber; Marie Tosolini; Gabriela Bindea; Christine Lagorce; Philippe Wind; Florence Marliot; Patrick Bruneval; Kurt Zatloukal; Zlatko Trajanoski; Anne Berger; Wolf-Herman Fridman; Jérôme Galon
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

7.  PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas.

Authors:  Ashley Cimino-Mathews; Elizabeth Thompson; Janis M Taube; Xiaobu Ye; Yao Lu; Alan Meeker; Haiying Xu; Rajni Sharma; Kristen Lecksell; Toby C Cornish; Nathan Cuka; Pedram Argani; Leisha A Emens
Journal:  Hum Pathol       Date:  2015-09-21       Impact factor: 3.466

Review 8.  PD-L1 as a biomarker of response to immune-checkpoint inhibitors.

Authors:  Deborah Blythe Doroshow; Sheena Bhalla; Mary Beth Beasley; Lynette M Sholl; Keith M Kerr; Sacha Gnjatic; Ignacio I Wistuba; David L Rimm; Ming Sound Tsao; Fred R Hirsch
Journal:  Nat Rev Clin Oncol       Date:  2021-02-12       Impact factor: 66.675

Review 9.  Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.

Authors:  Kaiyue Wu; Kangjia Lin; Xiaoyan Li; Xiangliang Yuan; Peiqing Xu; Peihua Ni; Dakang Xu
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

10.  Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer.

Authors:  Honglin Yan; Bin Luo; Xiaoyan Wu; Feng Guan; Xinxin Yu; Lina Zhao; Xiaokang Ke; Juan Wu; Jingping Yuan
Journal:  Int J Biol Sci       Date:  2021-06-22       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.